A retrospective comparison of drugs against COVID-19

DOI record: { "DOI": "10.1016/j.virusres.2020.198262", "ISSN": [ "0168-1702" ], "URL": "http://dx.doi.org/10.1016/j.virusres.2020.198262", "alternative-id": [ "S0168170220311692" ], "article-number": "198262", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "A retrospective comparison of drugs against COVID-19" }, { "label": "Journal Title", "name": "journaltitle", "value": "Virus Research" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.virusres.2020.198262" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 Elsevier B.V. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Tan", "given": "Jiahong", "sequence": "first" }, { "affiliation": [], "family": "Yuan", "given": "Yuan", "sequence": "additional" }, { "affiliation": [], "family": "Xu", "given": "Cheng", "sequence": "additional" }, { "affiliation": [], "family": "Song", "given": "Chunyan", "sequence": "additional" }, { "affiliation": [], "family": "Liu", "given": "Dan", "sequence": "additional" }, { "affiliation": [], "family": "Ma", "given": "Ding", "sequence": "additional" }, { "affiliation": [], "family": "Gao", "given": "Qinglei", "sequence": "additional" } ], "container-title": "Virus Research", "container-title-short": "Virus Research", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 12, 16 ] ], "date-time": "2020-12-16T08:26:11Z", "timestamp": 1608107171000 }, "deposited": { "date-parts": [ [ 2023, 10, 15 ] ], "date-time": "2023-10-15T11:08:31Z", "timestamp": 1697368111000 }, "funder": [ { "DOI": "10.13039/501100001809", "doi-asserted-by": "publisher", "name": "National Natural Science Foundation of China" } ], "indexed": { "date-parts": [ [ 2024, 4, 3 ] ], "date-time": "2024-04-03T11:20:37Z", "timestamp": 1712143237118 }, "is-referenced-by-count": 11, "issued": { "date-parts": [ [ 2021, 3 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 3, 1 ] ], "date-time": "2021-03-01T00:00:00Z", "timestamp": 1614556800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0168170220311692?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0168170220311692?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "198262", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 3 ] ] }, "published-print": { "date-parts": [ [ 2021, 3 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.5582/ddt.2020.03008", "article-title": "Treatment of SARS-CoV-2: How far have we reached?", "author": "Ahsan", "doi-asserted-by": "crossref", "first-page": "67", "issue": "2", "journal-title": "Drug Discov. Ther.", "key": "10.1016/j.virusres.2020.198262_bib0005", "volume": "14", "year": "2020" }, { "DOI": "10.1007/s00134-020-06022-5", "article-title": "Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)", "author": "Alhazzani", "doi-asserted-by": "crossref", "first-page": "854", "issue": "5", "journal-title": "Intensive Care Med.", "key": "10.1016/j.virusres.2020.198262_bib0010", "volume": "46", "year": "2020" }, { "DOI": "10.1016/j.jsps.2020.09.019", "article-title": "Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: a retrospective cohort study", "author": "Almazrou", "doi-asserted-by": "crossref", "journal-title": "J. Saudi Pharm. Soc.", "key": "10.1016/j.virusres.2020.198262_bib0015", "year": "2020" }, { "DOI": "10.1016/j.immuni.2020.03.007", "article-title": "SARS-CoV-2 vaccines: status report", "author": "Amanat", "doi-asserted-by": "crossref", "first-page": "583", "issue": "4", "journal-title": "Immunity", "key": "10.1016/j.virusres.2020.198262_bib0020", "volume": "52", "year": "2020" }, { "DOI": "10.1002/phar.2467", "article-title": "Hydroxychloroquine in hospitalized COVID‐19 patients: real world experience assessing mortality", "author": "Annie", "doi-asserted-by": "crossref", "journal-title": "Pharmacotherapy", "key": "10.1016/j.virusres.2020.198262_bib0025", "year": "2020" }, { "article-title": "Infectious diseases society of america guidelines on the treatment and management of patients with COVID-19", "author": "Bhimraj", "journal-title": "Clin. Infect. Dis.", "key": "10.1016/j.virusres.2020.198262_bib0030", "year": "2020" }, { "DOI": "10.1016/j.antiviral.2014.04.006", "article-title": "Arbidol as a broad-spectrum antiviral: an update", "author": "Blaising", "doi-asserted-by": "crossref", "first-page": "84", "journal-title": "Antiviral Res.", "key": "10.1016/j.virusres.2020.198262_bib0035", "volume": "107", "year": "2014" }, { "DOI": "10.1056/NEJMoa2001282", "article-title": "A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19", "author": "Cao", "doi-asserted-by": "crossref", "first-page": "1787", "issue": "19", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.virusres.2020.198262_bib0040", "volume": "382", "year": "2020" }, { "DOI": "10.1016/j.bbrc.2020.09.128", "article-title": "Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection", "author": "Carafoli", "doi-asserted-by": "crossref", "journal-title": "Biochem. Biophys. Res. Commun.", "key": "10.1016/j.virusres.2020.198262_bib0045", "year": "2020" }, { "DOI": "10.3389/fphar.2020.571156", "article-title": "Efficacy and safety of corticosteroid treatment in patients with COVID-19: a systematic review and meta-analysis", "author": "Cheng", "doi-asserted-by": "crossref", "journal-title": "Front. Pharmacol.", "key": "10.1016/j.virusres.2020.198262_bib0050", "volume": "11", "year": "2020" }, { "DOI": "10.1111/acem.14005", "article-title": "A rapid systematic review of clinical trials utilizing chloroquine and hydroxychloroquine as a treatment for COVID-19", "author": "Chowdhury", "doi-asserted-by": "crossref", "first-page": "493", "issue": "6", "journal-title": "Acad. Emerg. Med.", "key": "10.1016/j.virusres.2020.198262_bib0055", "volume": "27", "year": "2020" }, { "DOI": "10.1345/aph.1A363", "article-title": "Kaletra (lopinavir/ritonavir)", "author": "Corbett", "doi-asserted-by": "crossref", "first-page": "1193", "issue": "7–8", "journal-title": "Ann. Pharmacother.", "key": "10.1016/j.virusres.2020.198262_bib0060", "volume": "36", "year": "2002" }, { "DOI": "10.1016/j.jinf.2020.03.002", "article-title": "Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: a retrospective cohort study", "author": "Deng", "doi-asserted-by": "crossref", "first-page": "e1", "issue": "1", "journal-title": "J. Infect.", "key": "10.1016/j.virusres.2020.198262_bib0065", "volume": "81", "year": "2020" }, { "DOI": "10.1186/s13568-020-01028-0", "article-title": "The role of environmental factors to transmission of SARS-CoV-2 (COVID-19)", "author": "Eslami", "doi-asserted-by": "crossref", "first-page": "92", "issue": "1", "journal-title": "AMB Express", "key": "10.1016/j.virusres.2020.198262_bib0070", "volume": "10", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2020.9035", "article-title": "Caution needed on the use of chloroquine and hydroxychloroquine for coronavirus disease 2019", "author": "Fihn", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "JAMA Netw Open", "key": "10.1016/j.virusres.2020.198262_bib0075", "volume": "3", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret", "doi-asserted-by": "crossref", "issue": "1", "journal-title": "Int. J. Antimicrob. Agents", "key": "10.1016/j.virusres.2020.198262_bib0080", "volume": "56", "year": "2020" }, { "DOI": "10.1126/science.abb9332", "article-title": "Rapid repurposing of drugs for COVID-19", "author": "Guy", "doi-asserted-by": "crossref", "first-page": "829", "issue": "6493", "journal-title": "Science", "key": "10.1016/j.virusres.2020.198262_bib0085", "volume": "368", "year": "2020" }, { "article-title": "Repurposed antiviral drugs for COVID-19–interim WHO SOLIDARITY trial results", "author": "Hongchao Pan", "first-page": "15", "journal-title": "medRixv", "key": "10.1016/j.virusres.2020.198262_bib0090", "year": "2020" }, { "DOI": "10.1002/cti2.1136", "article-title": "Detection of IgM and IgG antibodies in patients with coronavirus disease 2019", "author": "Hou", "doi-asserted-by": "crossref", "issue": "5", "journal-title": "Clin. Transl. Immunol.", "key": "10.1016/j.virusres.2020.198262_bib0095", "volume": "9", "year": "2020" }, { "DOI": "10.2174/0929867324666170316115938", "article-title": "The pharmacological mechanisms and therapeutic activities of hydroxychloroquine in rheumatic and related diseases", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "2241", "issue": "20", "journal-title": "Curr. Med. Chem.", "key": "10.1016/j.virusres.2020.198262_bib0100", "volume": "24", "year": "2017" }, { "article-title": "Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19", "author": "Kavanagh", "first-page": "143", "journal-title": "Med. Hypotheses", "key": "10.1016/j.virusres.2020.198262_bib0105", "year": "2020" }, { "DOI": "10.1056/NEJMoa2001316", "article-title": "Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia", "author": "Li", "doi-asserted-by": "crossref", "first-page": "1199", "issue": "13", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.virusres.2020.198262_bib0110", "volume": "382", "year": "2020" }, { "article-title": "Efficacy and safety of Lopinavir/Ritonavir or arbidol in adult patients with Mild/Moderate COVID-19: an exploratory randomized controlled trial", "author": "Li", "journal-title": "Med.", "key": "10.1016/j.virusres.2020.198262_bib0115", "year": "2020" }, { "DOI": "10.1002/ctm2.119", "article-title": "Alteration of serum markers in COVID-19 and implications on mortality", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "e119", "journal-title": "Clin. Transl. Med.", "key": "10.1016/j.virusres.2020.198262_bib0120", "year": "2020" }, { "DOI": "10.1002/jmv.25678", "article-title": "Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle", "author": "Lu", "doi-asserted-by": "crossref", "first-page": "401", "issue": "4", "journal-title": "J. Med. Virol.", "key": "10.1016/j.virusres.2020.198262_bib0125", "volume": "92", "year": "2020" }, { "DOI": "10.2807/1560-7917.ES.2020.25.15.2000125", "article-title": "Coronavirus disease (COVID-19): a scoping review", "author": "Lv", "doi-asserted-by": "crossref", "issue": "15", "journal-title": "Euro Surveill.", "key": "10.1016/j.virusres.2020.198262_bib0130", "volume": "25", "year": "2020" }, { "DOI": "10.2165/00003495-200161020-00011", "article-title": "Oseltamivir: a review of its use in influenza", "author": "McClellan", "doi-asserted-by": "crossref", "first-page": "263", "issue": "2", "journal-title": "Drugs", "key": "10.1016/j.virusres.2020.198262_bib0135", "volume": "61", "year": "2001" }, { "DOI": "10.1016/j.phrs.2020.104859", "article-title": "Candidate drugs against SARS-CoV-2 and COVID-19", "author": "McKee", "doi-asserted-by": "crossref", "journal-title": "Pharmacol. Res.", "key": "10.1016/j.virusres.2020.198262_bib0140", "volume": "157", "year": "2020" }, { "DOI": "10.1128/JVI.02077-15", "article-title": "The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses", "author": "Pécheur", "doi-asserted-by": "crossref", "first-page": "3086", "issue": "6", "journal-title": "J. Virol.", "key": "10.1016/j.virusres.2020.198262_bib0145", "volume": "90", "year": "2016" }, { "DOI": "10.1016/j.nmni.2020.100776", "article-title": "Hydroxychloroquine is effective, and consistently so used early, for Covid-19: a systematic review", "author": "Prodromos", "doi-asserted-by": "crossref", "journal-title": "New Microbes New Infect.", "key": "10.1016/j.virusres.2020.198262_bib0150", "year": "2020" }, { "article-title": "Lower COVID-19 mortality in Italian forested areas suggests immunoprotection by Mediterranean plants", "author": "Roviello", "first-page": "1", "journal-title": "Environ. Chem. Lett.", "key": "10.1016/j.virusres.2020.198262_bib0155", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30317-2", "article-title": "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury", "author": "Russell", "doi-asserted-by": "crossref", "first-page": "473", "issue": "10223", "journal-title": "Lancet (London, England)", "key": "10.1016/j.virusres.2020.198262_bib0160", "volume": "395", "year": "2020" }, { "DOI": "10.3389/fphar.2020.585888", "article-title": "Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena", "author": "Samaddar", "doi-asserted-by": "crossref", "journal-title": "Front. Pharmacol.", "key": "10.1016/j.virusres.2020.198262_bib0165", "volume": "11", "year": "2020" }, { "DOI": "10.1001/jama.2020.6019", "article-title": "Pharmacologic treatments for coronavirus disease 2019 (COVID-19)", "author": "Sanders", "doi-asserted-by": "crossref", "journal-title": "Jama", "key": "10.1016/j.virusres.2020.198262_bib0170", "year": "2020" }, { "DOI": "10.1016/S1473-3099(06)70361-9", "article-title": "New insights into the antiviral effects of chloroquine", "author": "Savarino", "doi-asserted-by": "crossref", "first-page": "67", "issue": "2", "journal-title": "Lancet Infect. Dis.", "key": "10.1016/j.virusres.2020.198262_bib0175", "volume": "6", "year": "2006" }, { "article-title": "Drug repurposing approach to fight COVID-19", "author": "Singh", "first-page": "1", "journal-title": "Pharmacol. Rep.", "key": "10.1016/j.virusres.2020.198262_bib0180", "year": "2020" }, { "DOI": "10.3390/ijms21072657", "article-title": "A review of SARS-CoV-2 and the ongoing clinical trials", "author": "Tu", "doi-asserted-by": "crossref", "issue": "7", "journal-title": "Int. J. Mol. Sci.", "key": "10.1016/j.virusres.2020.198262_bib0185", "volume": "21", "year": "2020" }, { "DOI": "10.1002/rmv.2143", "article-title": "Drugs against SARS‐CoV‐2: What do we know about their mode of action?", "author": "Valle", "doi-asserted-by": "crossref", "journal-title": "Rev. Med. Virol.", "key": "10.1016/j.virusres.2020.198262_bib0190", "year": "2020" }, { "DOI": "10.1001/jama.2020.1585", "article-title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "1061", "issue": "11", "journal-title": "Jama", "key": "10.1016/j.virusres.2020.198262_bib0195", "volume": "323", "year": "2020" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "269", "issue": "3", "journal-title": "Cell Res.", "key": "10.1016/j.virusres.2020.198262_bib0200", "volume": "30", "year": "2020" }, { "DOI": "10.1093/cid/ciaa272", "article-title": "Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "769", "issue": "15", "journal-title": "Clin. Infect. Dis.", "key": "10.1016/j.virusres.2020.198262_bib0205", "volume": "71", "year": "2020" }, { "article-title": "Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized", "author": "Wei Tang", "journal-title": "controlled trial. medRixv", "key": "10.1016/j.virusres.2020.198262_bib0210", "year": "2020" }, { "author": "WHO", "key": "10.1016/j.virusres.2020.198262_bib0215", "series-title": "COVID-19 Weekly Epidemiological Update", "year": "2020" }, { "DOI": "10.1001/jama.2020.2648", "article-title": "Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention", "author": "Wu", "doi-asserted-by": "crossref", "journal-title": "Jama", "key": "10.1016/j.virusres.2020.198262_bib0220", "year": "2020" }, { "DOI": "10.1001/jamainternmed.2020.0994", "article-title": "Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "1", "issue": "7", "journal-title": "JAMA Intern. Med.", "key": "10.1016/j.virusres.2020.198262_bib0225", "volume": "180", "year": "2020" }, { "DOI": "10.1007/s40495-020-00216-7", "article-title": "An update on current therapeutic drugs treating COVID-19", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "56", "issue": "3", "journal-title": "Curr. Pharmacol. Rep.", "key": "10.1016/j.virusres.2020.198262_bib0230", "volume": "6", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "first-page": "732", "issue": "15", "journal-title": "Clin. Infect. Dis.", "key": "10.1016/j.virusres.2020.198262_bib0235", "volume": "71", "year": "2020" }, { "article-title": "An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)", "author": "Yueping Li", "journal-title": "medRixv", "key": "10.1016/j.virusres.2020.198262_bib0240", "year": "2020" }, { "article-title": "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial", "author": "Zhaowei Chen", "journal-title": "medRixv", "key": "10.1016/j.virusres.2020.198262_bib0245", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)31208-3", "article-title": "Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial", "author": "Zhu", "doi-asserted-by": "crossref", "first-page": "1845", "issue": "10240", "journal-title": "Lancet (London, England)", "key": "10.1016/j.virusres.2020.198262_bib0250", "volume": "395", "year": "2020" }, { "DOI": "10.1056/NEJMoa2001017", "article-title": "A novel coronavirus from patients with pneumonia in China, 2019", "author": "Zhu", "doi-asserted-by": "crossref", "first-page": "727", "issue": "8", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.virusres.2020.198262_bib0255", "volume": "382", "year": "2020" } ], "reference-count": 51, "references-count": 51, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0168170220311692" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Cancer Research", "Infectious Diseases", "Virology" ], "subtitle": [], "title": "A retrospective comparison of drugs against COVID-19", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "294" }